ID: ALA164926

Max Phase: Preclinical

Molecular Formula: C10H14N4O3

Molecular Weight: 238.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(CO)OCn1cnc2c(O)ncnc21

Standard InChI:  InChI=1S/C10H14N4O3/c1-2-7(3-15)17-6-14-5-13-8-9(14)11-4-12-10(8)16/h4-5,7,15H,2-3,6H2,1H3,(H,11,12,16)

Standard InChI Key:  PIAIQOFCDIINSS-UHFFFAOYSA-N

Associated Targets(Human)

ATH-8 cell line 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 238.25Molecular Weight (Monoisotopic): 238.1066AlogP: 0.28#Rotatable Bonds: 5
Polar Surface Area: 93.29Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.68CX Basic pKa: 0.70CX LogP: 0.53CX LogD: 0.53
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.78Np Likeness Score: 0.00

References

1. Abushanab E, Sarma MS..  (1989)  1',2'-seco-dideoxynucleosides as potential anti-HIV agents.,  32  (1): [PMID:2909746] [10.1021/jm00121a016]

Source